BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 32920953)

  • 21. Complex context relationships between DNA methylation and accessibility, histone marks, and hTERT gene expression in acute promyelocytic leukemia cells: perspectives for all-trans retinoic acid in cancer therapy.
    Garsuault D; Bouyer C; Nguyen E; Kandhari R; Prochazkova-Carlotti M; Chevret E; Forgez P; Ségal-Bendirdjian E
    Mol Oncol; 2020 Jun; 14(6):1310-1326. PubMed ID: 32239597
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Single-cell imaging reveals unexpected heterogeneity of telomerase reverse transcriptase expression across human cancer cell lines.
    Rowland TJ; Dumbović G; Hass EP; Rinn JL; Cech TR
    Proc Natl Acad Sci U S A; 2019 Sep; 116(37):18488-18497. PubMed ID: 31451652
    [TBL] [Abstract][Full Text] [Related]  

  • 23. TERT promoter hypermethylation is associated with poor prognosis in adrenocortical carcinoma.
    Svahn F; Paulsson JO; Stenman A; Fotouhi O; Mu N; Murtha TD; Korah R; Carling T; Bäckdahl M; Wang N; Juhlin CC; Larsson C
    Int J Mol Med; 2018 Sep; 42(3):1675-1683. PubMed ID: 29956721
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epigenetic landscape of the TERT promoter: a potential biomarker for high risk AML/MDS.
    Zhao X; Tian X; Kajigaya S; Cantilena CR; Strickland S; Savani BN; Mohan S; Feng X; Keyvanfar K; Dunavin N; Townsley DM; Dumitriu B; Battiwalla M; Rezvani K; Young NS; Barrett AJ; Ito S
    Br J Haematol; 2016 Nov; 175(3):427-439. PubMed ID: 27433923
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combined genetic and epigenetic alterations of the TERT promoter affect clinical and biological behavior of bladder cancer.
    Leão R; Lee D; Figueiredo A; Hermanns T; Wild P; Komosa M; Lau I; Mistry M; Nunes NM; Price AJ; Zhang C; Lipman T; Poyet C; Valtcheva N; Oehl K; Coelho H; Sayyid R; Gomes AM; Prado E Castro L; Sweet J; Vinagre J; Apolónio J; Stephens D; Faleiro I; Fadaak K; Richard PO; Kulkarni G; Zlotta AR; Hamilton RJ; Castelo-Branco P; Tabori U
    Int J Cancer; 2019 Apr; 144(7):1676-1684. PubMed ID: 30350309
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dual role of allele-specific DNA hypermethylation within the TERT promoter in cancer.
    Lee DD; Komosa M; Sudhaman S; Leão R; Zhang CH; Apolonio JD; Hermanns T; Wild PJ; Klocker H; Nassiri F; Zadeh G; Diplas BH; Yan H; Gallinger S; Pugh TJ; Ramaswamy V; Taylor MD; Castelo-Branco P; Nunes NM; Tabori U
    J Clin Invest; 2021 Nov; 131(21):. PubMed ID: 34720085
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recurrent TERT promoter mutations identified in a large-scale study of multiple tumour types are associated with increased TERT expression and telomerase activation.
    Huang DS; Wang Z; He XJ; Diplas BH; Yang R; Killela PJ; Meng Q; Ye ZY; Wang W; Jiang XT; Xu L; He XL; Zhao ZS; Xu WJ; Wang HJ; Ma YY; Xia YJ; Li L; Zhang RX; Jin T; Zhao ZK; Xu J; Yu S; Wu F; Liang J; Wang S; Jiao Y; Yan H; Tao HQ
    Eur J Cancer; 2015 May; 51(8):969-76. PubMed ID: 25843513
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epigenetic regulation of human telomerase reverse transcriptase promoter activity during cellular differentiation.
    Liu L; Saldanha SN; Pate MS; Andrews LG; Tollefsbol TO
    Genes Chromosomes Cancer; 2004 Sep; 41(1):26-37. PubMed ID: 15236314
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CTCF mediates the TERT enhancer-promoter interactions in lung cancer cells: identification of a novel enhancer region involved in the regulation of TERT gene.
    Eldholm V; Haugen A; Zienolddiny S
    Int J Cancer; 2014 May; 134(10):2305-13. PubMed ID: 24174344
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeting oncogenic TERT promoter variants by allele-specific epigenome editing.
    Kouroukli AG; Rajaram N; Bashtrykov P; Kretzmer H; Siebert R; Jeltsch A; Bens S
    Clin Epigenetics; 2023 Nov; 15(1):183. PubMed ID: 37993930
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tianshengyuan-1 (TSY-1) regulates cellular Telomerase activity by methylation of TERT promoter.
    Yu W; Qin X; Jin Y; Li Y; Santiskulvong C; Vu V; Zeng G; Zhang Z; Chow M; Rao J
    Oncotarget; 2017 Jan; 8(5):7977-7988. PubMed ID: 28002788
    [TBL] [Abstract][Full Text] [Related]  

  • 32.
    Liu T; Li S; Xia C; Xu D
    Front Immunol; 2022; 13():1071390. PubMed ID: 36713366
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hypomethylated CpG around the transcription start site enables TERT expression and HPV16 E6 regulates TERT methylation in cervical cancer cells.
    Jiang J; Zhao LJ; Zhao C; Zhang G; Zhao Y; Li JR; Li XP; Wei LH
    Gynecol Oncol; 2012 Mar; 124(3):534-41. PubMed ID: 22108635
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cloning of mouse telomerase reverse transcriptase gene promoter and identification of proximal core promoter sequences essential for the expression of transgenes in cancer cells.
    Si SY; Song SJ; Zhang JZ; Liu JL; Liang S; Feng K; Zhao G; Tan XQ
    Oncol Rep; 2011 Aug; 26(2):377-82. PubMed ID: 21567104
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aberrant methylation of the TERT promoter in esophageal squamous cell carcinoma.
    Deng J; Zhou D; Zhang J; Chen Y; Wang C; Liu Y; Zhao K
    Cancer Genet; 2015 Dec; 208(12):602-9. PubMed ID: 26669682
    [TBL] [Abstract][Full Text] [Related]  

  • 36. TERT Promoter Mutations Enhance Telomerase Activation by Long-Range Chromatin Interactions.
    Min J; Shay JW
    Cancer Discov; 2016 Nov; 6(11):1212-1214. PubMed ID: 27807101
    [TBL] [Abstract][Full Text] [Related]  

  • 37. TERT-Regulation and Roles in Cancer Formation.
    Dratwa M; Wysoczańska B; Łacina P; Kubik T; Bogunia-Kubik K
    Front Immunol; 2020; 11():589929. PubMed ID: 33329574
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Telomerase reverse transcriptase regulates DNMT3B expression/aberrant DNA methylation phenotype and AKT activation in hepatocellular carcinoma.
    Yu J; Yuan X; Sjöholm L; Liu T; Kong F; Ekström TJ; Björkholm M; Xu D
    Cancer Lett; 2018 Oct; 434():33-41. PubMed ID: 30017965
    [TBL] [Abstract][Full Text] [Related]  

  • 39. TERT promoter methylation is significantly associated with TERT upregulation and disease progression in pituitary adenomas.
    Miyake Y; Adachi JI; Suzuki T; Mishima K; Araki R; Mizuno R; Nishikawa R
    J Neurooncol; 2019 Jan; 141(1):131-138. PubMed ID: 30392088
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regulation of the human catalytic subunit of telomerase (hTERT).
    Daniel M; Peek GW; Tollefsbol TO
    Gene; 2012 May; 498(2):135-46. PubMed ID: 22381618
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.